SEC 13F Intelligence

Jabodon Pt Co / PCRX

Jabodon Pt Co’s Pacira Biosciences Inc Position

Does Jabodon Pt Co own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 49.1K shares worth $4M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2022
Shares
49.1K
% of Portfolio
+1.70%
Quarters Held
3
position exited

Position History PCRX

Reported value by quarter
Q3 ’21: $4MQ3 ’21Q4 ’21: $3MQ4 ’21Q1 ’22: $4MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202249.1K$4M+1.70%
Q4 202151.1K$3M+1.40%
Q3 202172.9K$4M+1.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jabodon Pt Co’s full portfolio or all institutional holders of PCRX.